Molecules 2014, 19
15895
3.2. Experimental Procedures
3.2.1. Synthesis of Radical Precursors
The synthesis of radical precursors acetate 1a [20], and sulfonamides 1b and 1c [21] has been
previously reported.
Ethyl (2E)-4-[(2-iodo-4-methylphenyl)(methyl)amino]-4-oxobut-2-enoate (1d). 4-Methyl-morpholine
(1.60 g, 15.9 mmol) was added to a suspension of fumaric acid monoethyl ester (2.30 g, 15.9 mmol) and
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (4.40 g, 15.9 mmol) in THF (50 mL)
and the suspension was stirred at room temperature for 20 min. A solution of 2-iodo–p-toluidine (3.35 g,
14.4 mmol) in THF (5 mL) was added and the suspension was stirred overnight. The reaction mixture
was diluted with water, extracted with diethyl ether washed with saturated NaHCO3, water, 2%
hydrochloric acid, brine, dried (NaSO4), and evaporated. The residue was added to a mixture of sodium
hydride (0.371 g, 15.4 mmol) in THF (25 mL), which was cooled to 0 °C. The solution was stirred for
30 min at 0 °C and at room temperature for another 30 min. Methyl iodide (2.74 g, 19.3 mmol) was added
and the reaction was stirred for 2 h. The solvent was evaporated and the residue dissolved in ethyl acetate,
washed with water, dried (MgSO4) and evaporated. The resulting crude was recrystallized from diethyl
ether to give the title compound (3.65 g, 68%) as an off-white solid; mp 76–80 °C; vmax (neat, cm−1)
2925, 1716 (C=O), 1663 (C=O), 1633, 1489, 1419, 1375, 1295, 1174, 1127, 1059, 1033; δH (400 MHz,
CDCl3) 1.24 (t, J 7.1 Hz, 3H, CH3), 2.35 (s, 3H, CH3), 3.23 (s, 3H, NCH3), 4.15 (q, J 7.1 Hz, 2H, OCH2),
6.63 (d, J 15.3 Hz, 1H), 6.87 (d, J 15.3 Hz, 1H), 7.10 (d, J 8.0 Hz, 1H, 6-H), 7.20 (dd, J 8.0, 1.1 Hz, 1H,
5-H), 7.74 (d, J 1.1 Hz, 1H, 3-H); δC (100 MHz, CDCl3) 14.2 (CH3CH2), 20.7 (CH3), 36.7 (NCH3), 61.1
(OCH2), 99.1 (C), 128.7 (6-CH), 130.9 (5-CH), 131.6, 133.8 (CH), 140.8 (3-CH), 140.9, 142.1 (C),
164.2, 165.8 (C=O). HRMS (ESI) m/z (M+H)+, C14H17NO3I calcd. 374.0253, observed 374.0248.
Ethyl (2E)-4-[benzyl(2-iodophenyl)amino]-4-oxobut-2-enoate (1e). Same procedure as for the synthesis
of 1d was followed, except 2-iodoaniline (3.15 g, 14.4 mmol) and benzyl bromide (7.39 g, 43.2 mmol)
were used, and the crude was purified by dry vacuum column chromatography with gradient elution of
petroleum ether and ethyl acetate to give the title compound (5.07 g, 81%) as an off-white solid; Rf 0.52
(1:4 EtOAc/Pet); mp 64–66 °C; vmax (neat, cm−1) 3031, 2981, 1720 (C=O), 1662 (C=O), 1637, 1577,
1468, 1388, 1292, 1160, 1082, 1023; δH (400 MHz, CDCl3) 1.23 (t, J 7.1 Hz, 3H, CH3), 4.08 (d, J 14.2 Hz,
1H, NCHH), 4.14 (q, J 7.1 Hz, 2H, OCH2), 5.66 (d, J 14.2 Hz, 1H, NCHH), 6.58 (d, J 15.2 Hz, 1H), 6.71
(dd, J 7.8, 1.6 Hz, 1H, 6-H), 6.93 (d, J 15.2 Hz, 1H), 7.06 (td, J 7.9, 1.6 Hz, 1H), 7.18–7.27 (m, 6H),
7.93 (dd, J 7.9, 1.4 Hz, 1H, 3-H); δC (100 MHz, CDCl3) 14.2 (CH3), 52.3 (NCH2), 61.1 (OCH2), 100.3 (C),
127.9, 128.6, 129.4, 129.6, 130.5 (CH), 131.0 (6-CH), 132.2, 133.8 (CH), 136.3 (C), 140.5 (3-CH), 142.6
(C) 163.9, 165.6 (C=O). HRMS (ESI) m/z (M+H)+, C19H19NO3I calcd. 436.0410, observed 436.0414.
(2E)-N-(2-iodophenyl)-N,N',N'-trimethylbut-2-enediamide (1f). 4-((2-Iodophenyl)(methyl)amino)-4-
oxobut-2(E)-enoic acid [21] (0.300 g, 0.9 mmol), oxalyl chloride (0.15 mL, 1.8 mmol) and DMF
(0.70 mL, 9.1 mmol) were stirred in dichloromethane (10 mL) at room temperature for 12 h. The mixture
was evaporated to dryness, and the residue was dissolved in dichloromethane (10 mL), and triethylamine
(0.50 mL, 3.6 mmol) added, and stirred at room temperature for 6 h. The mixture was washed with brine